Global Endocrine Testing Market 2015-2019

内分泌検査の世界市場:臨床化学技術、免疫アッセイ技術、モノクローナル抗体/リクローナル抗体技術、タンデム質量分析技術、センサー技術

◆タイトル:Global Endocrine Testing Market 2015-2019
◆商品コード:IRTNTR6125
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年6月10日
◆ページ数:101
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Five UserUSD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、内分泌検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、内分泌検査の世界市場規模及び予測、種類別分析、技術別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Endocrine Testing Systems
Endocrine testing system refers to a collection of tests that involve all the glands of the body and the hormones produced by those glands. The endocrine system together with nervous system regulates and controls many internal body functions. While the endocrine system uses chemical messengers called hormones, the nervous system uses nerve impulses as a means of control. The endocrine system plays a role in reproduction, growth and sexual development, responses to injury and stress, body energy levels, bone and muscle strength, and internal balance of the body.
Technavio’s analysts forecast the global endocrine testing market to grow at a CAGR of 4.66% over the period 2014-2019.

[Covered in this Report]
In this report, Technavio covers the present scenario and the growth prospects of the global endocrine testing market for the period 2015-2019. To calculate the market size, we consider the revenue generated from the sales of the products (instruments and reagents) used in the following endocrine testing technologies:
Types of Diagnostic Technologies
• Clinical chemistry technologies
• Immunoassay technologies
• Tandem mass spectrometry
• Monoclonal and polyclonal antibodies
• Sensor technologies
• Others
The report also provides information about the following endocrine tests:
• FSH
• TSH
• hCG
• DHEAS
• Progesterone
• Testosterone
• Insulin
• Prolactin
• Cortisol
• Estradiol
• Luteinizing Hormone
This report covers the present scenario and the growth prospects of the endocrine testing market for the period 2015-2019 mainly for three regions:
Americas: The principal countries in the Americas are the US, Canada, Mexico, and Brazil.
EMEA: The principal countries focused in this region are the UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and UAE.
APAC: The principal countries focused in this region are Japan, China, Australia, Singapore, South Korea, and India.
Technavio’s report, Global Endocrine Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Abbott Diagnostics
• Diascorin
• Roche Diagnostics
• Siemens Healthcare
• Thermo Fisher Scientific
Other Prominent Vendor
• AdnaGen
• Alere
• Allele Biotechnology
• Axis-Shield
• Beckman Coulter/Danaher
• Biomedical Diagnostics
• BioMerieux
• Bio-Rad
• Diametra
• Enzo Life Sciences
• Fujirebio
• ImmunoDX
• Immunonodiagnostics System
• InDevR
• Innogenetics
• Kyowa Medex
• Merck Millipore
• Meridian Bioscience
• Meso Scale Discovery
• NanoEnTek
• Nova Century Scientific
• Ortho-Clinical Diagnostics
• Quidel
• Randox
• SDIX
• Sysmex
• Tecan
• Tosoh Bioscience
• Vital Diagnostics
• ZEUS Scientific

[Market Driver]
• Growing Aging Population
• For a full, detailed list, view our report

[Market Challenge]
• Limited Detection and Complexity of Immunoassays
• For a full, detailed list, view our report

[Market Trend]
• Automation and System Integration
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07.Market Segmentation by Tests

08.Market Segmentation by Diagnostic Technology
08.1 Global Clinical Chemistry Technology Market
08.1.1 Market Size and Forecast
08.2 Global Immunoassay Technology Market
08.2.1 Market Size and Forecast
08.3 Global Monoclonal and Polyclonal Antibodies Technology Market
08.3.1 Market Size and Forecast
08.4 Global Tandem Mass Spectrometry Technology Market
08.4.1 Market Size and Forecast
08.5 Global Sensor Technology Market
08.5.1 Market Size and Forecast

09.Geographical Segmentation
09.1 Endocrine Testing Market in Americas
09.1.1 Market Size and Forecast
09.2 Endocrine Testing Market in EMEA
09.2.1 Market Size and Forecast
09.3 Endocrine Testing Market in APAC
09.3.1 Market Size and Forecast

10.Buying Criteria

11.Market Growth Drivers

12.Drivers and their Impact

13.Market Challenges

14.Impact of Drivers and Challenges

15.Market Trends

16.Trends and their Impact

17.Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.2.1 Abbott
17.2.2 DiaSorin
17.2.3 Roche
17.2.4 Siemens Healthcare
17.2.5 Thermo Fisher
17.3 Other Prominent Vendors

18.Key Vendor Analysis
18.1 Abbott Diagnostics
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Geographical Presence
18.1.4 SWOT Analysis
18.2 DiaSorin
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2013
18.2.4 Business Segmentation by Revenue 2012 and 2013
18.2.5 Geographical Segmentation by Revenue 2013
18.2.6 Business Strategy
18.2.7 Recent Developments
18.2.8 SWOT Analysis
18.3 Roche Diagnostics
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2014
18.3.4 Business Segmentation by Revenue 2013 and 2014
18.3.5 Geographical Segmentation by Revenue 2014
18.3.6 Business Strategy
18.3.7 Recent Developments
18.3.8 SWOT Analysis
18.4 Siemens Healthcare Diagnostics
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 SWOT Analysis
18.5 Thermo Fisher Scientific
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Business Segmentation by Revenue 2014
18.5.4 Business Segmentation by Revenue 2013 and 2014
18.5.5 Geographical Segmentation by Revenue 2014
18.5.6 Business Strategy
18.5.7 Recent Developments
18.5.8 SWOT Analysis

19.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Snapshot of Global Endocrine Testing Market 2014-2019
Exhibit 3: Global Endocrine Testing Market 2014-2019 ($ millions)
Exhibit 4: Global Endocrine Testing Market Segmentation by Type of Tests
Exhibit 5: Global Endocrine Testing Market Segmentation by Type of Tests 2014
Exhibit 6: Normal FSH Level (depends on age and gender)
Exhibit 7: TSH Standard Reference Levels
Exhibit 8: TSH Levels during Pregnancy
Exhibit 9: hCG Levels in Early Pregnancy
Exhibit 10: DHEAS Levels
Exhibit 11: Progesterone Levels During Different Phases of the Menopause Cycle and Pregnancy
Exhibit 12: Normal Levels of Testosterone
Exhibit 13: Glucose Levels
Exhibit 14: Standard Levels of Prolactin
Exhibit 15: Normal Cortisol Levels
Exhibit 16: Normal Estradiol Levels
Exhibit 17: Normal LH Levels
Exhibit 18: Segmentation of Global Endocrine Testing Market by Type of Diagnostic Technology
Exhibit 19: Segmentation of Global Endocrine Testing Market by Technology 2014
Exhibit 20: Global Clinical Chemistry Technology Market 2014-2019 ($ millions)
Exhibit 21: Global Immunoassay Technology Market 2014-2019 ($ millions)
Exhibit 22: Global Monoclonal and Polyclonal Antibodies Technology Market 2014-2019 ($ millions)
Exhibit 23: Global Tandem Mass Spectrometry Technology Market 2014-2019 ($ millions)
Exhibit 24: Global Sensor Technology Market 2014-2019 ($ millions)
Exhibit 25: Global Endocrine Testing Market Segmentation Analysis 2014-2019
Exhibit 26: Segmentation of Global Endocrine Testing Market by Type of Technology 2014-2019
Exhibit 27: Global Endocrine Testing Market by Geographical Segmentation 2014
Exhibit 28: Endocrine Testing Market in Americas 2014-2019 ($ millions)
Exhibit 29: Endocrine Testing Market in EMEA 2014-2019 ($ millions)
Exhibit 30: Endocrine Testing Market in EMEA 2014-2019 ($ millions)
Exhibit 31: Global Endocrine Testing Market by Geography 2014-2019 in ($ millions)
Exhibit 32: Global Endocrine Testing Market by Geography 2014-2019
Exhibit 33: Percentage of Elderly Aged above 65 in Different Regions 2012 and 2050
Exhibit 34: Estimated Percentage of Elderly Population 2012 and 2050
Exhibit 35: Abbott: Key Takeaways
Exhibit 36: DiaSorin: Revenue by Technology 2014
Exhibit 37: DiaSorin: Key Takeaways
Exhibit 38: Roche: Key Takeaways
Exhibit 39: Siemens Healthcare: Key Takeaways
Exhibit 40: Thermo Fisher: Key Takeaways
Exhibit 41: Abbott Diagnostics: Geographical Presence
Exhibit 42: DiaSorin: Business Segmentation by Revenue 2013
Exhibit 43: DiaSorin: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 44: DiaSorin: Geographical Segmentation by Revenue 2013
Exhibit 45: Roche Diagnostics: Business Segmentation by Revenue 2014
Exhibit 46: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
Exhibit 47: Roche Diagnostics: Geographical Segmentation by Revenue 2014
Exhibit 48: Thermo Fisher Scientific: Business Segmentation by Revenue 2014
Exhibit 49: Thermo Fisher Scientific: Business Segmentation by Revenue 2013 and 2014 ($ billion)
Exhibit 50: Thermo Fisher Scientific: Geographical Segmentation by Revenue 2014



【掲載企業】

Abbott Diagnostics, Diascorin, Roche Diagnostics, Siemens Healthcare, Thermo Fisher Scientific, AdnaGen, Alere, Allele Biotechnology, Axis-Shield, Beckman Coulter/Danaher, Biomedical Diagnostics, BioMerieux, Bio-Rad, Diametra, Enzo Life Sciences, Fujirebio, ImmunoDX, Immunonodiagnostics System, InDevR, Innogenetics, Kyowa Medex, Merck Millipore, Meridian Bioscience, Meso Scale Discovery, NanoEnTek, Nova Century Scientific, Ortho-Clinical Diagnostics, Quidel, Randox, SDIX, Sysmex, Tecan, Tosoh Bioscience, Vital Diagnostics, ZEUS Scientific

【資料のキーワード】

内分泌検査装置、内分泌検査技術、臨床化学技術、免疫アッセイ技術、モノクローナル抗体技術、ポリクローナル抗体技術、タンデム質量分析技術、センサー技術、内分泌診断

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[内分泌検査の世界市場:臨床化学技術、免疫アッセイ技術、モノクローナル抗体/リクローナル抗体技術、タンデム質量分析技術、センサー技術] (Global Endocrine Testing Market 2015-2019 / IRTNTR6125)販売に関する免責事項
[内分泌検査の世界市場:臨床化学技術、免疫アッセイ技術、モノクローナル抗体/リクローナル抗体技術、タンデム質量分析技術、センサー技術] (Global Endocrine Testing Market 2015-2019 / IRTNTR6125)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆